View Post

2019 Conference

In All by Sheryl Lunsford

The 11th International Conference on HHV-6 & 7 will be held in beautiful Quebec City, Canada June 23–26, 2019.

View Post

HHV-6B reactivates first, proceeds to end organ disease faster in transplant patients

In All, Gastrointestinal, Transplant Complications by Kristin Loomis

Investigators at Fred Hutch Cancer Research Center found that HHV-6B is the first DNA virus to reactivate at a median of 3 weeks, compared to CMV, EBV and Adenovirus at 5-6 weeks. HHV-6B also peaked rapidly, unlike other DNA viruses that took 3-6 weeks to reach peak viral load. HHV-6B reactivation resulted in increased mortality after 100 days.

View Post

Ancient iciHHV-6 genomes vary considerably from community strains, but still capable of reactivation

In All, ciHHV-6 by Kristin Loomis

British researchers used molecular dating methods to determine that most strains of iciHHV-6 come from a small number of ancient human ancestors; the youngest found lived over 24,000 years ago. These ancient strains vary considerably from modern non-inherited strains of HHV-6A and appear just as likely to activate as their more modern cousins.

View Post

New HHV-6 NIH grants awarded in 2017

In All by Kristin Loomis

Two new NIH grants awarded for studies related to HHV-6A and CNS disease. A Stanford group was also funded to develop whole genome sequencing platform to study HHV-6 and four other viruses post-transplant.